- Lumentum reported adjusted earnings per share of $4.57 for the first fiscal quarter, exceeding the market estimate of $4.21; it expects net revenue for the second fiscal quarter to be between $1.58 billion and $1.63 billion, higher than the market estimate of $1.48 billion.
- Market Cap Surges by $1 Trillion in Nearly Four Months, 36x P/E Ratio Hits Highest Since 2008: Apple (AAPL.US) Earnings Leave No Room for Disappointment
- Market capitalization has surged by $1 trillion in nearly four months, with a price-to-earnings ratio of 36 times hitting the highest level since 2008: Apple's (AAPL.US) earnings report leaves no room for disappointment.
- Deutsche Bank raises Microsoft target price to $620
- Tower Semiconductor expects fourth-quarter revenue of $600 million, higher than expected
- Deutsche Bank Adjusts Target Prices for Pinterest and Roblox
- Xcel Energy plans to issue $2.0 billions in convertible senior notes maturing in 2027
- M Cash Integrasi Total Liabilities Rise 26.6% to Rp 948.02 Billion at End-September
- GENERAL DYNAMICS CORP <GD.N>: CITIGROUP RAISES TARGET PRICE TO $400 FROM $374
- Quarterly refinancing statement due on Wednesday, U.S. Treasury market holds its breath for major signals
- Leonardo schedules shareholder meeting
- ABBVIE : CITIGROUP RAISES TARGET PRICE TO $295 FROM $260
- Updated Version 1 - Marriott raises annual room revenue growth forecast as travel demand remains resilient
- PORTLAND GENERAL ELECTRIC CO : BMO CUTS TARGET PRICE TO $47 FROM $48
- XCEL ENERGY <XEL.O>: BMO RAISES TARGET PRICE TO $90 FROM $87
- Alamtri Minerals Confirms Thohir, Subianto, Rachmat Families and Edwin Soeryadjaya as Ultimate Controllers
- Capital Power management commentary cites stronger PJM prices, summer demand as drivers of Q3 2026 adjusted EBITDA growth
- WEST FRASER TIMBER CO. LTD. <WFG.N>: BMO CUTS TARGET PRICE TO $87 FROM $90
- EQUINIX, INC. <EQIX.O>: BMO RAISES TARGET PRICE TO $1250 FROM $1225
- Goldsky Resources appoints Teemu Törmälehto as Nordic exploration manager
- AECON GROUP INC. : STIFEL RAISES TARGET PRICE TO C$75 FROM C$66
- TOROMONT INDUSTRIES LTD <TIH.TO>: RBC CUTS TARGET PRICE TO C$261 FROM C$265
- ADC Therapeutics Sets Third-Quarter Financial Results Release
- Emira Property Fund sets R 200 million debt repayment for November 24
- Marvell Technology: Maintaining Midpoint of Its Prior Rev Guidance While Narrowing Expected Range to Plus or Minus 2%, Vs Original Range of Plus or Minus 5% >MRVL
- WELLTOWER INC. <WELL.N>: BMO RAISES TARGET PRICE TO $270 FROM $265
- APPLIED OPTOELECTRONICS, INC. : NORTHLAND CAPITAL RAISES TO OUTPERFORM FROM MARKET PERFORM
- VENTAS, INC. <VTR.N>: BMO CUTS TARGET PRICE TO $100 FROM $107
- COHERENT CORP. <COHR.N>: NORTHLAND CAPITAL RAISES TO OUTPERFORM FROM MARKET PERFORM
- Marvell Technology: Reports Preliminary Rev for 3Q of Fiscal 2027 Consistent With Previously Provided Guidance >MRVL
- FEDERAL REALTY INVESTMENT TRUST <FRT.N>: BMO CUTS TARGET PRICE TO $130 FROM $135
- EXELON CORP <EXC.O>: BMO RAISES TARGET PRICE TO $47 FROM $45
- Marvell Technology, Lumentum: Transaction Expected to Close in the 1H of Calendar Yr 2028 >MRVL
- Marvell Technology, Lumentum: Following Closing, Matt Murphy Will Continue as Chmn and CEO of Combined Co >MRVL
- Marvell Technology, Lumentum: Current Marvell Stockholders Will Own About 67% of Combined Co While Lumentum Stockholders Will Own About 33% >MRVL
- ALLIANT ENERGY CORP <LNT.O>: BMO RAISES TARGET PRICE TO $79 FROM $76
- CHENIERE ENERGY, INC. <LNG.N>: BMO RAISES TARGET PRICE TO $350 FROM $306
- Marvell Technology, Lumentum: Lumentum Stockholders Will Receive a Fixed Exchange Ratio of 4.500 Shrs of Marvell Common Stk for Each Shr of Lumentum Common Stk They Own >MRVL
- Karyopharm Therapeutics: Ayrmid Will Serve as Lead Bidder in Court-Supervised Sale Process >KPTI
- Marvell Technology, Lumentum: Transaction Has an Implied Enterprise Value of $115B for Lumentum >MRVL
- REGENERON PHARMACEUTICALS, INC. <REGN.O>: BMO RAISES TARGET PRICE TO $1050 FROM $920
- Karyopharm files for Chapter 11 to pursue Ayrmid merger
- Japan Lifeline Publishes Transcript of FY2027 Q2 Financial Results Briefing
- ABBVIE : BMO RAISES TARGET PRICE TO $340 FROM $300
- Karyopharm Therapeutics: Remains Focused on Supporting Patients and Advancing Its Programs in Multiple Myeloma and Myelofibrosis >KPTI
- BLUE OWL CAPITAL INC. <OWL.N>: BMO RAISES TARGET PRICE TO $12 FROM $11
- LPL FINANCIAL HOLDINGS INC. <LPLA.O>: BMO CUTS TARGET PRICE TO $320 FROM $370
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Karyopharm Therapeutics Inc. Announces Planned Merger With Ayrmid Ltd. To Strengthen Company For The Future >KPTI
- INVESCO LTD <IVZ.N>: BMO CUTS TARGET PRICE TO $33 FROM $36
- Marvell agrees to acquire Lumentum
- Major Drilling acquires Bunbury Drilling for up to AUD 70 million
- American Lithium Increases Measured and Indicated Uranium Resources at Macusani Project
- RZOLV Partners With Aurquest Alaska on North Vancouver Metal Recovery Facility
- Arya Resources relocates historic copper-gold trenches at Wedge Lake property
- NorthStrive Acquisition Corp I agrees to combine with Nuclea Energy
- Rapport Therapeutics closes $172.5 million convertible senior notes offering
- Rare Earths Americas reports 40% rare earth leach recovery in Alpha lab tests
- Tower Semiconductor Q3 net profit more than doubles year over year to $119.89 million
- Marriott Q3 diluted EPS rises 14% year over year to $3.04
- Nortec Minerals starts Phase 2 exploration at Barker Bay gold project
- Verdera Energy Gets TSX Venture Exchange OK for New Normal Course Issuer Bid >V.V
- NorthStrive Acquisition I: Proposed Deal Values Nuclea Energy at an Enterprise Value of $350M >NSAIU
- Verdera Energy To Buy Back Up to 6.39 Million Shares, or About 9.44% of Adjusted Public Float >V.V
- GAMESTOP CORP. <GME.N>: STONEX INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $33
- SUNation Energy confidentially submits draft SEC registration statement for Suniva merger
- Metriks AI signs deal to acquire 60% stake in Lunghi Informatica
- CINEMARK HOLDINGS INC <CNK.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $44 FROM $40
- Eton Reports FDA Application Submission for ET-900 Phase 2 Spasm Trial
- MIDCAP FINANCIAL INVESTMENT CORP <MFIC.O>: TRUIST SECURITIES CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $11 FROM $12
- Decade Resources Plans Flow-Through Private Placement of Up to $2.17 Million
- Ocular Therapeutix Schedules Third-Quarter Financial Results Call
- Marvell Narrows Fiscal Q3 2027 Revenue Guidance Range to Plus or Minus 2%, Maintains Midpoint
- Krystal Biotech 3Q EPS $2.05 >KRYS
- Spectral Medical Also Announces Conversion of $4.5M of Maturing Convertible Notes and Repayment of $4.5M of Maturing Convertible Notes>EDT.T
- Krystal Biotech Board Authorizes Share-Repurchase Program of Up to $400M >KRYS
- NASDAQ TRADE HALT <KPTI.O> HALT NEWS PENDING AT 07:07 AM
- NASDAQ TRADE HALT CONTINUES <UCFI.O> REASON NOT AVAILABLE AT 07:07 AM
- VICI PROPERTIES INC <VICI.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $28 FROM $30
- Krystal Biotech 3Q Rev $127.3M >KRYS
- BRIEF-Equinor CEO says European gas storage levels at lowest in 15 years
- CORRECTED-BRIEF-NAPCO Q1 EPS USD 0.36
- Eton Pharmaceuticals Starts New Program to Evaluate Mecasermin in Treating Spasms
- Matador's San Mateo Signs Delaware Basin Gas Deals
- Deutsche Bank Adjusts Lear Price Target to $121 From $122, Maintains Hold Rating
- --Deutsche Bank Adjusts Garrett Motion Price Target to $30 From $32, Maintains Buy Rating
- Tower Semiconductor's Q3 Adjusted Earnings, Revenue Rise; Provides Q4 Revenue Guidance
- Axsome Therapeutics Q3 Loss Narrows, Revenue Increases - Shares Up Pre-Bell
- GeoPark's Venezuela Production Participation Contract Takes Effect
- Krystal Biotech Q3 Net Income Falls, Revenue Rises; Shares Up Pre-Bell
- --Raymond James Downgrades Farmers National Banc to Market Perform From Outperform
- Pecoy Copper to Raise CA$49.8 Million Via Private Placement Led by Hudbay Minerals
- --HC Wainwright Upgrades Inovio Pharmaceuticals to Buy From Neutral, Price Target is $5
- --Hovde Group Upgrades First Carolina Financial Services to Outperform From Market Perform, Price Target is $15
- --Marvell Technology to Acquire Lumentum in $115 Billion All-Stock Deal
- --Earnings Flash (SPTX) Seaport Therapeutics Posts Q3 Loss $0.49 a Share, vs. FactSet Est of $0.57 Loss
- --Street Color: Marvell Technology Agrees to Acquire Lumentum For $115 Billion
